Immediate Impact

20 standout
Sub-graph 1 of 9

Citing Papers

Transformative Potential of AI in Healthcare: Definitions, Applications, and Navigating the Ethical Landscape and Public Perspectives
2024 Standout
European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)—A Summary of the 2024 Guidelines Update
2024 Standout
2 intermediate papers

Works of Nessn Azawi being referenced

DaBlaCa-13 Study: Oncological Outcome of Short-Term, Intensive Chemoresection With Mitomycin in Nonmuscle Invasive Bladder Cancer: Primary Outcome of a Randomized Controlled Trial
2022
The DaBlaCa-13 Study: Short-term, Intensive Chemoresection Versus Standard Adjuvant Intravesical Instillations in Non–muscle-invasive Bladder Cancer—A Randomised Controlled Trial
2020
and 1 more

Author Peers

Author Last Decade Papers Cites
Nessn Azawi 321 203 89 78 527
Marjorie Hertz 324 136 33 47 600
Mohammed Shahait 204 364 57 88 607
Bing Liu 310 132 72 68 554
Marc A. Furrer 409 195 41 65 590
Mohamed E. Ahmed 229 147 60 71 567
Nicholas Kavoussi 151 283 111 48 492
Gonca Topuzlu Tekant 362 185 61 45 492
Neil Oakley 191 328 46 93 541
Eugenio Rossi 273 189 27 61 549
B. Haluk Güvenç 358 105 41 57 507

All Works

Loading papers...

Rankless by CCL
2026